PharmaTher prepares FDA package for ketamine Phase 3 Parkinson's study
Tweet Send to a Friend
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) announced it is preparing FDA briefing materials for a Phase 3 program testing ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


